In contrast to SRC-2, SRC-1 and SRC-3 are frequently overexpressed in a subset of breast cancers, and correlate with a more aggressive tumour phenotype and poor prognosis and resistance to endocrine treatment [4], [23]–[28]. The gene discussed is NCOA3; the disease is breast cancer.